• FREEMAN Andrew

    I am head of Medical Policy at GlaxoSmithKline (GSK) and chair our internal governance committee for clinical study disclosure. I have been involved in clinical study transparency for over 15 years which has included; - The development of GSK’s policy on public disclosure of clinical research and launch of the GSK clinical study register in 2005. - Leading GSK's patient level data sharing initiative which launched in 2013 - Collaborating with other pharma companies on the development of a data sharing portal- Clinical Study Data Request.com (https://www.clinicalstudydatarequest.com/) - Published papers on data sharing including: Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry. Vallance P, Freeman A, Stewart M. PLoS Med. 2016 Jan 5;13(1) Data Sharing at a Crossroads. Rockhold F, Nisen P, Freeman A. N Engl J Med. 2016 Sep 22;375(12):1115-7.
    Tel: +33 825 595 525 (€0,15/min)
     Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE 39 chemin du vieux chêne, 38240 Meylan / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.

    www.esof.eu Twitter: @ESOF_eu #ESOF2018 Facebook: @ESOF.eu